Nitric oxide is implicated in the pathogenesis of various neuropathologies characterized by oxidative stress. Although 
Introduction
Nitric oxide, endogenously synthesized in the mammalian system by the nitric oxide synthases (NOS), continues to receive widespread attention for its multifunctional roles in both physiological and patho-physiological conditions. Under physiological conditions, nitric oxide exerts pleiotrophic effects in different tissues. For instances, within the vascular-endothelial system, nitric oxide functions as an effective vaso-relaxant [1] . However, when present in the central and peripheral nervous systems, nitric oxide functions as a neurotransmitter [2] . On the other hand, nitric oxide is an antitumoral and antimicrobial defense agent produced by immune and glial cells in the context of mammalian host immunity [3] .
With a half-life of only 3-5 sec in vivo, nitric oxide can readily enter a cell or move between cells many times within this time span [4] and react with the heme group of guanylate cyclase (GC), triggering a conformational change in GC and the catalysis of guanosine-5Ј-triphosphate (GTP) to cyclic guanosine 3Ј,5Ј-monophosphate (cGMP) [4] and protein phosphorylation. GC activation is believed to be the main nitrergic signal transduction pathway. cGMP acts as a second messenger that activates protein kinase G 1 and 2, with the former involved in intracellular Ca 2ϩ
control and the latter regulating anionic influx, for example chloride [5, 6] 
. This transduction pathway can affect a broad range of proteins directly, for example phosphodiesterases of cyclic nucleotides and indirectly, for example protein kinase A, thus increasing the level of adenosine 3Ј,5Ј-monophosphate (cAMP)
with activation of proteins involved in the cAMP downstream pathway [7, 8] . [9] . [10] , nitration [11] or nitrosylation [12] . The involvement of diverse functional nitric oxide in the nervous system continues to attract researchers' attention as its implication in various neurodegenerative disorders linked to oxidative stress, including ischaemia [13] , amyotrophic lateral sclerosis [14] , Alzheimer's disease (AD) [15] and Parkinson's disease (PD) [16] .
Nitric oxide is capable of affecting other cellular signalling pathways independent of GC activation. As nitric oxide is thermodynamically unstable, it is able to undergo various chemical reactions with gaseous molecules, anions and reactive oxygen species (ROS) to form nitrites, nitrates and peroxynitrites (ONOO Ϫ
)
During the process of these chemical reactions, intermediate products such as (ROS) and other free radicals are produced. These nitrergic intermediate and end-products can induce modifications of lipids, proteins and DNA through oxidation

The bi-phasic role of nitric oxide either as a physiological neuromodulator or a neurotoxic factor is dependent on the level of intracellular nitric oxide. Nitric oxide induced cytotoxicity is significantly elevated in pathological conditions implicating the generation of ROS and ONOO
Ϫ as a key mechanism in brain injury where they are both likely to mediate programmed cell death (PCD) [17, 18] . Moreover, iNOS induction by diverse stimuli such as endotoxins or cytokines and during excitotoxicity caused by constitutive activation of glutamate receptors can result in overproduction of nitric oxide because of increased nNOS activity [19] . Chronic Aß1-40 intracerebroventricular infusion in an AD model has been demonstrated to induce ONOO Ϫ formation resulting in nitration of tyrosyl residues of proteins [20] . In ischaemia/reperfusion and stroke models, the higher nitric oxide level is accounted for by increased synthesis activity of iNOS and the constitutive isoforms of NOS triggered by elevated Ca 2ϩ level [21] . However, the role of nitric oxide in ischaemia remains controversial. Inhibition of nitric oxide production in iNOS and nNOS knockout mice or by nonselective pharmacological inhibitor has demonstrated neuroprotective effects in models of cerebral ischaemia [22] and traumatic brain injury [23] , respectively. On the contrary, [24] demonstrated that pre-treatment with NOS inhibitor aggravated neuronal death whereas post-treatment showed no neuronal rescue effect on cerebral ischaemia injury. In PD, inhibition of parkin [25] and glutathione reductase [26] 
Microarray bioinformatics analysis
The absolute data (signal intensity, detection call and detection P value) were exported into GeneSpring (tm) GX 7.3 
control). (B) Round shrunken apoptotic bodies with chromatin condensation were observed in nitric oxide induced neuronal injury. Hoffman imaging of control (i) and 0.5 mM NOC-18-treated (ii) primary cortical neurons was performed after 24 hrs post-treatment (Top). Hoechst nuclei stain was subsequently carried out to reveal extent of chromatin condensation in control (iii) and nitric oxide treated (iv) neurons (Bottom
Real-time PCR
Reverse transcription was carried out according to steps specified by manufacturer (Applied Biosystems Taqman reverse transcription reagents). Each cDNA sample was duplicated with two No Template Control (NTC) for each probe used. Twenty microlitres of the Taqman master mix was pipetted to the bottom of each well of the optical 96-well fast reaction plate. Five microlitres of cDNA or water (NTC) was added to the designated reaction well. The plate was then read by the 7000 Fast Real-Time PCR System with conditions according to the manufacturer's protocol.
Statistical analysis
Values are mean Ϯ S.E.M. of at least three independent experiments. Data were analysed using Tukey test with one-way ANOVA to assess significant differences in multiple comparisons. Values of P Ͻ 0.05 were considered as statistically significant and presented as mean Ϯ S.E. Figure 1A (Fig. 2B) . These data are suggestive of PCD, which is slow in onset and involves the recruitment of multiple proteases [18] . (Fig. 3A) . As demonstrated in Figure 3A, (24 hrs) . This tremendous increase was attributed to the expansion of the Ն2-fold change category from the initial 22% (8 hrs) to an escalating 58% (15 hrs) , and continued on a slow steady increase to 73% (24 hrs) . A similar trend was also observed for the down-regulated gene probes (Fig. 3) [28, 29] . DAVID interpretation recognized 3484 biologically and functionally reported genes from various biological databases for nitric oxide treatment (as shown in Fig. 4 [30] [31] [32] .
Results
Nitric oxide induced apoptotic cell death in cultured primary neurons
High doses of nitric oxide, frequently observed in the pathogenesis of neurodegenerative disease, cause neuronal death. In this study, we adopt a neuronal model of cultured day 7 murine primary cortical neurons. Cell viability assay demonstrated a concentration-dependent decrease in cell viability after 24 hrs treatment with NOC-18 (a nitric oxide donor; Fig. 1A). As determined from
Gene expression in nitric oxide induced neuronal apoptosis
In this study, we focus on the over-represented biological processes (with EASE-determined P Ͻ 0.05) induced in nitric oxide mediated neuronal injury ( 
